Canadian Sec - Delayed Quote CAD

Biosenta Inc. (ZRO.CN)

Compare
0.1000 +0.0150 (+17.65%)
At close: November 15 at 3:00 PM EST
Loading Chart for ZRO.CN
DELL
  • Previous Close 0.0850
  • Open 0.0900
  • Bid 0.0950 x --
  • Ask 0.1000 x --
  • Day's Range 0.0850 - 0.1000
  • 52 Week Range 0.0550 - 0.8900
  • Volume 23,500
  • Avg. Volume 16,313
  • Market Cap (intraday) 3.186M
  • Beta (5Y Monthly) -0.02
  • PE Ratio (TTM) --
  • EPS (TTM) -0.2400
  • Earnings Date Jan 27, 2025 - Jan 31, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Biosenta Inc. develops, manufactures, and sells chemical compounds for household and industrial applications in Canada. The company develops True, an anti-microbial, dual-action disinfectant for destroying viruses, bacteria, germs, molds, mildew, and fungi. It also manufactures and distributes Tri-Filler, an anti-microbial filler to perform filling and bulking functions. The company is based in Toronto, Canada.

www.biosenta.com

--

Full Time Employees

September 30

Fiscal Year Ends

Recent News: ZRO.CN

View More

Performance Overview: ZRO.CN

Trailing total returns as of 11/15/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

ZRO.CN
54.55%
S&P/TSX Composite index
18.76%

1-Year Return

ZRO.CN
74.68%
S&P/TSX Composite index
24.31%

3-Year Return

ZRO.CN
81.13%
S&P/TSX Composite index
14.34%

5-Year Return

ZRO.CN
42.86%
S&P/TSX Composite index
46.66%

Compare To: ZRO.CN

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: ZRO.CN

View More

Valuation Measures

Annual
As of 11/15/2024
  • Market Cap

    3.19M

  • Enterprise Value

    8.55M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    15.15

  • Price/Book (mrq)

    --

  • Enterprise Value/Revenue

    42.53

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    -217.27%

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    200.98k

  • Net Income Avi to Common (ttm)

    -6.74M

  • Diluted EPS (ttm)

    -0.2400

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    6.3k

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    -1.3M

Research Analysis: ZRO.CN

View More

Company Insights: ZRO.CN

Research Reports: ZRO.CN

View More

People Also Watch